Associated Papers
Disease activity accounts for long-term efficacy of IL-1 blockers in pyogenic sterile arthritis pyoderma gangrenosum and severe acne syndrome.
Omenetti A et al.
Rheumatology (oxford, England), 2016
Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).
Demidowich AP et al.
Arthritis and Rheumatism, 2012
Clinical, Molecular, and Genetic Characteristics of PAPA Syndrome: A Review.
Smith EJ et al.
Current Genomics, 2010
Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome): report of a sporadic case without an identifiable mutation in the CD2BP1 gene.
Hong JB et al.
Journal of the American Academy of Dermatology, 2009
Select a paper to view details